Intellectual Property Cases
Cases 61 - 70 of 277
AstraZeneca AB et al v. Apotex Inc. et al
as 1:2018cv02010
Plaintiff: AstraZeneca Pharmaceuticals LP, AstraZeneca AB and Nektar Therapeutics
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Genzyme Corp. et al v. Apotex Corp. et al
as 1:2018cv01795
Plaintiff: The Regents of the University of Michigan and Genzyme Corp.
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
Anacor Pharmaceuticals, Inc. v. Ascent Pharmaceuticals, Inc. et al
as 1:2018cv01673
Defendant: Cipla Limited, Perrigo Company plc, Taro Pharmaceuticals U.S.A., Inc. and others
Plaintiff: Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Bayer Healthcare LLC et al v. Apotex Inc. et al
as 1:2018cv01539
Plaintiff: Bayer HealthCare Pharmaceuticals Inc., Onyx Pharmaceuticals, Inc. and Bayer Healthcare LLC
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. APOTEX INC. et al
as 3:2018cv14202
Plaintiff: KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC and others
Defendant: APOTEX CORP. and APOTEX INC.
Cause Of Action: 35 U.S.C. § 271
Bayer Healthcare LLC et al v. Apotex, Inc. et al
as 1:2018cv01465
Plaintiff: Bayer HealthCare Pharmaceuticals Inc. and Bayer Healthcare LLC
Defendant: Apotex Corp. and Apotex, Inc.
Cause Of Action: 35 U.S.C. § 271
Amgen Inc. et al v. Apotex Inc et al
as 0:2018cv61828
Defendant: Apotex Inc and Apotex Corp.
Plaintiff: Amgen Inc. and Amgen Manufacturing Limited
Cause Of Action: 35 U.S.C. § 0271
Dexcel Pharma Technologies Ltd. et al v. Apotex Corp. et al
as 1:2018cv05190
Plaintiff: Dexcel Pharma Technologies Ltd. and Dexcel Ltd.
Defendant: Apotex Corp. and Apotex Inc.
Cause Of Action: 28 U.S.C. § 1331
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01043
Defendant: Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant: Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Apotex Inc., et al.
as 1:2018cv01038
Defendant: Apotex Corp. and Apotex Inc.
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?